Comparative cardioprotective effect of Egyptian Silybum marianum extract and Chinese silymarin in experimentally liver fibrosis.

Silymarin for the Prevention of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction

Doxorubicin-induced cardiotoxicity in mice; protection by silymarin

SILYMARIN AMELIORATES DIETHYLNITROSAMINE-INDUCED LIVER FIBROSIS IN WISTAR RATS

ANTICLASTOGENIC ACTIVITY OF THE DRUG SILYMARIN

Effect of Effervescent Formulation of Silymarin against Experimental Hepatotoxicity in Rats: Involvement of NRF2/HO-1, PI3K/AKT and TLR4/NFκB Pathways

Evaluation of the cardioprotective effect of l-carnitine and silymarin in cancer patients receiving anthracycline-containing chemotherapy

Protective effects of Gemfibrozil, Silymarin, and their combination on liver ischemic/reperfusion insult in rats

EFFECT OF SILYMARIN AS NATURAL ANTIOXIDANTS AND ANTIMICROBIAL ACTIVITY

Silymarin protects against sepsis-induced acute liver and kidney injury via anti-inflammatory and antioxidant mechanisms in the rat